AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Doxorubicin, Cyclophosphamide|DRUG: doxorubicin, Capecitabine
Sponsor: Peking Union Medical College Hospital